Stock Price Forecast

March 25, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Q32 Bio Inc. chart...

About the Company

We do not have any company description for Q32 Bio Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

131

Exchange

Nasdaq

$72M

Total Revenue

131

Employees

$54M

Market Capitalization

-0.42

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $FIXX News

Q32 Bio Inc

1mon ago, source: CNN

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in ...

Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million

1mon ago, source: Morningstar

March 25, 2024 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis ...

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer

1mon ago, source: Stockhouse

WALTHAM, Mass., April 3, 2024 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, ...

Q32 Bio Inc. Common Stock (QTTB) Short Interest

9d ago, source: Nasdaq

Nasdaq provides information of company’s short interest and the average days it takes to cover them. Short interest and days to cover can be used to indicate market sentiment and gauge the stock ...

Q32 Bio Inc. Common Stock (QTTB) Historical NOCP

9d ago, source: Nasdaq

*Today’s High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours. Nasdaq Official Closing Price (NOCP)" is a process for ...

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer

1mon ago, source: Yahoo Finance

WALTHAM, Mass., April 3, 2024 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune ...

Q32 Bio Inc QTTB

11d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Q32 Bio Inc. (QTTB)

1mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Q32 Bio Inc (QTTB)

24d ago, source: Investing

On Wednesday, Oppenheimer began coverage of Q32 Bio Inc. (NASDAQ: QTTB), assigning the stock an Outperform rating and setting a price target of $50.00. The firm's optimism is ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...